Driving Impact: CGA-IGC’s 2026 CRC Awareness Month Campaign

We’re excited to once again serve as a resource for our members and the wider hereditary GI cancer community during the 2026 Colorectal Cancer Awareness Month.

At CGA-IGC, our mission is to empower healthcare professionals with the knowledge they need to care for patients with hereditary GI cancer. 

Thanks again to our wonderful Communication Committee members who have been working tirelessly to create this month's content. This would not be possible without their hard work and dedication. Thank you!

Fight CRC shared that early-onset colorectal cancer continues to rise, with 1 in 5 new cases diagnosed in adults under 55. At the same time, an estimated 1 in 279 people in the U.S, nearly 1 million individuals, are living with Lynch syndrome. These individuals are in our communities and clinics. Yet important gaps remain in risk recognition, referral for genetic evaluation, screening, and multidisciplinary coordination.

CGA-IGC is fortunate to count many leading hereditary GI cancer experts as members and is committed to removing barriers so multidisciplinary teams across the Americas can access the most current, evidence-based information. No matter your role - gastroenterologist, genetic counselor, advanced practice provider, nurse practitioner, physician assistant, social worker, psychologist, surgeon, oncologist, geneticist, or another provider caring for families affected by colorectal or hereditary GI cancers, staying informed directly improves outcomes.

This year, each week during Colorectal Cancer Awareness Month we’ll spotlight a different theme:

• Week 1: Advocacy - highlighting Fight CRC’s initiatives, including United in Blue, Call on Congress, and updates on early-onset CRC. Learn more about Fight CRC's initiatives HERE!

• Week 2: Research in colorectal cancer, including diet and nutrition.

• Week 3: JEDI-related topics and ongoing disparities in care.

• Week 4: Lynch syndrome and the outstanding work and resources from our members.

  
  

Our vision is to eliminate morbidity and early mortality from hereditary GI cancers and this will only be achieved if the patient remains at the center of our discovery, research, and education efforts.  Be part of the effort to learn, collaborate, and improve outcomes for the families you serve.

If you know of other initiatives, please tag us on social media (X, Linkedin, Bluesky or Instagram) or contact us here.